# Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility

> **NCT02234128** · NA · COMPLETED · sponsor: **Lung Bioengineering Inc.** · enrollment: 118 (actual)

## Conditions studied

- Lung Disease

## Interventions

- **DEVICE:** Toronto EVLP System™

## Key facts

- **NCT ID:** NCT02234128
- **Lead sponsor:** Lung Bioengineering Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-18
- **Primary completion:** 2018-11-21
- **Final completion:** 2019-11-07
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234128, "Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02234128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*